Deciphering Puerarin’s Therapeutic Potential Against LPS-Induced Nephrotoxicity: A Computational and Animal Model Study
- 9 September 2025
- journal article
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1617-1635
Abstract
The current project aimed to determine the protective effect of Puerarin against lipopolysaccharide (LPS)-induced renal injury using animal and computational models. The LPS is the integral component of the outer layer of gram-negative bacteria and is associated with multiple organ damage, including the kidney. The animals were pre-treated with the drugs, and following pre-treatment, the animals were administered LPS intraperitoneally (IP). The LPS administration showed a higher mortality rate, i.e., 45%. The Puerarin-treated groups showed marked protection against the LPS-induced mortality compared to the LPS-treated group. The Puerarin administration showed marked improvement in the body temperature, and the wet-to-dry ratio was reduced significantly as compared to only the LPS-treated group. The in vivo activity was followed by the computational studies using docking, molecular dynamics simulation, and binding free energy calculations. The molecular docking of Puerarin was performed against the 3GQL, TGF-B, STAT, SMAD2, and JAK to assess the binding affinity. Following the molecular docking, the MD simulation was performed for 50 ns, and the results showed dynamic stability of the complexes. After the MD simulation, the binding free energy was calculated to validate the results of the molecular docking and MD simulation. In conclusion, Puerarin showed significant activity against LPS-induced renal injury using both in vivoand computational studies; however, further studies will be required to employ Puerarin for the clinical treatment of renal injury.Keywords
Funding Information
- Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University (PNURSP2025R465)
This publication has 47 references indexed in Scilit:
- STAT3 Signaling Pathway in Health and DiseaseMedcomm, 2025
- Macrophages in the inflammatory response to endotoxic shockImmunity, Inflammation and Disease, 2024
- The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compoundsBiomedicine & Pharmacotherapy, 2024
- Fevogrit, a polyherbal medicine, mitigates endotoxin (lipopolysaccharide)‐induced fever in Wistar rats by regulating pro‐inflammatory cytokine levelsAnimal Models and Experimental Medicine, 2024
- Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targetsInternational Immunopharmacology, 2020
- The newly synthesized compounds (NCHDH and NTHDH) attenuates LPS-induced septicemia and multi-organ failure via Nrf2/HO1 and HSP/TRVP1 signaling in miceChemico-Biological Interactions, 2020
- Continentalic acid exhibited nephroprotective activity against the LPS and E. coli-induced kidney injury through inhibition of the oxidative stress and inflammationInternational Immunopharmacology, 2020
- Epigallocatechin gallate potentially abrogates fluoride induced lung oxidative stress, inflammation via Nrf2/Keap1 signaling pathway in rats: An in-vivo and in-silico studyInternational Immunopharmacology, 2016
- The Specific Roles of JAK/STAT Signaling Pathway in SepsisInflammation, 2015
- Biopharmaceutics classification of puerarin and comparison of perfusion approaches in ratsInternational Journal of Pharmaceutics, 2014